Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2026-05-12 @ 2:30 PM
Study NCT ID:
NCT03142334
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-13
First Post:
2017-05-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Sponsor:
Organization: